Cargando…
Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
Reimbursement agencies in several countries now require health outcomes to be measured in terms of quality-adjusted life-years (QALYs), leading to an immense increase in publications reporting QALY gains. However, there is a growing concern that the various ‘multi-attribute utility’ (MAU) instrument...
Autores principales: | Wisløff, Torbjørn, Hagen, Gunhild, Hamidi, Vida, Movik, Espen, Klemp, Marianne, Olsen, Jan Abel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964297/ https://www.ncbi.nlm.nih.gov/pubmed/24477679 http://dx.doi.org/10.1007/s40273-014-0136-z |
Ejemplares similares
-
Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014) -
More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model
por: Pike, Eva, et al.
Publicado: (2017) -
Setting Dead at Zero: Applying Scale Properties to the QALY Model
por: Roudijk, Bram, et al.
Publicado: (2018) -
The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015) -
A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis
por: Hamidi, Vida, et al.
Publicado: (2018)